Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Clinical Lung Cancer|July 6, 2011
Long-term safety and tolerability of sorafenib in patients with advanced non-small-cell lung cancer: a case-based reviewAlex A Adjei, George R Blumenschein, Sumithra Mandrekar, et al.
Oncology Nursing Forum|June 12, 2002
Learning and support preferences of adult patients with cancer at a comprehensive cancer centerJane Harper Chelf, Amy M B Deshler, Kay M B Thiemann, et al.
Cancers|November 7, 2020
Adverse Event Burden Score-A Versatile Summary Measure for Cancer Clinical TrialsJennifer G Le-Rademacher, Shauna Hillman, Elizabeth Storrick, et al.
JNCI Cancer Spectrum|January 17, 2024
Patient-targeted education (ePRO-E) to increase ePRO intent within an Alliance clinical trial (A221805-SI1)Ellen M Lavoie Smith, Youmin Cho, Shauna Hillman, et al.
Cancer|June 23, 2015
Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trialDamian E Dupuy, Hiran C Fernando, Shauna Hillman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 25, 2003
Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patientsAminah Jatoi, Shauna Hillman, Philip J Stella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment GroupAminah Jatoi, Shauna Hillman, Philip Stella, et al.
American Journal of Clinical Oncology|October 7, 2003
Weekly carboplatin and paclitaxel in elderly non-small-cell lung cancer patients (>or=65 years of age): a phase II North Central Cancer Treatment Group studyAminah Jatoi, Philip J Stella, Shauna Hillman, et al.
Cancer|May 7, 2003
Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment GroupJames R Jett, Alan K Hatfield, Shauna Hillman, et al.
The Annals of Thoracic Surgery|September 4, 2013
Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable patientsMichael Kent, Rodney Landreneau, Sumithra Mandrekar, et al.
Pageof 2